TIGECYCLINE-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
TIGECYCLINE-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 (255 working days)
Active ingredients
tigecycline
Registration type
New generic medicine
Indication
Tigecycline-AFT is indicated for the treatment of the following infections in adults:
- Complicated skin and skin structure infections, including those with methicillin-resistant
Staphylococcus aureus (MRSA), where there is suspected or proven resistance to,
intolerance of, or there are co-morbidities preventing the use of, other available agents.
- Complicated intra-abdominal infections, where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.